Metalloproteinases in Inflammatory Bowel Diseases

Código QR

Metalloproteinases in Inflammatory Bowel Diseases

Martin Marônek,1,* Irene Marafini,2,* Roman Gardlík,1 René Link,3 Edoardo Troncone,2 Giovanni Monteleone2 1Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University in Bratislava, Bratislava, 81108, Slovakia; 2Department of Systems Medicine, Univers...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marônek M, Marafini I, Gardlík R, Link R, Troncone E, Monteleone G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	tissue inhibitor of metalloproteinases crohn’s disease ulcerative colitis intestinal inflammation Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/d0a7c1322028476daa88e1e76a36e3cf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cathelicidin – A Novel Potential Marker of Pediatric Inflammatory Bowel Disease
por: Krawiec P, et al.
Publicado: (2021)

The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane ER, et al.
Publicado: (2017)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini I, et al.
Publicado: (2020)

Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease
por: Al-Meghaiseeb ES, et al.
Publicado: (2016)

Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A review of 740 patients in Fars province, Southern Iran.
por: John F.Mayberry
Publicado: (2013)

Psoriasis and inflammatory bowel disease: links and risks
por: Vlachos C, et al.
Publicado: (2016)

Indeterminate Colitis – Update on Treatment Options
por: Venkateswaran N, et al.
Publicado: (2021)

Frequency of Oral Manifestation in Patients with Inflammatory Bowel Disease in Chile
por: Oviedo,C, et al.
Publicado: (2017)

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
por: Zhang Y, et al.
Publicado: (2021)

The Anti-Inflammatory Effect of Pistacia Lentiscus in a Rat Model of Colitis
por: Ostovan M, et al.
Publicado: (2020)

A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Byron P. Vaughn
Publicado: (2021)

Electroacupuncture at ST36 Relieves Visceral Hypersensitivity via the NGF/TrkA/TRPV1 Peripheral Afferent Pathway in a Rodent Model of Post-Inflammation Rectal Hypersensitivity [Erratum]
por: Chen Y, et al.
Publicado: (2021)

Electroacupuncture at ST36 Relieves Visceral Hypersensitivity via the NGF/TrkA/TRPV1 Peripheral Afferent Pathway in a Rodent Model of Post-Inflammation Rectal Hypersensitivity
por: Chen Y, et al.
Publicado: (2021)

Fecal calprotectin and microbiota of the gut
por: V. G. Gorokhova, et al.
Publicado: (2016)

Factores ambientales en el desarrollo y evolución de la enfermedad inflamatoria intestinal
por: Meligrana,Noelia E., et al.
Publicado: (2019)

Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A review of 740 patients in Fars province, Southern Iran
por: Murat Kekilli, et al.
Publicado: (2013)

Inflammatory bowel disease: clinical aspects and treatments
por: Fakhoury M, et al.
Publicado: (2014)

Liver Pathology in Children with Diagnosed Inflammatory Bowel Disease—A Single Center Experience
por: Urszula Daniluk, et al.
Publicado: (2021)

Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
por: Rawla P, et al.
Publicado: (2018)

MiRNA-29c-3p Promotes Intestinal Inflammation via Targeting Leukemia Inhibitory Factor in Ulcerative Colitis
por: Guo J, et al.
Publicado: (2021)

ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis
por: Boshagh MA, et al.
Publicado: (2019)

Genetic Variants of DMBT1 and SFTPD and Disease Severity in Paediatric Inflammatory Bowel Disease—A Polish Population-Based Study
por: Aleksandra Glapa-Nowak, et al.
Publicado: (2021)

Editorial: Game Changers in Inflammatory Bowel Diseases
por: Anita Bálint, et al.
Publicado: (2021)

Antioxidant and Anti-Inflammatory Effects of Gel and Aqueous Extract of Melilotus officinalis L. in Induced Ulcerative Colitis: A Rattus norvegicus Model
por: Ali Reza Safarpour, et al.
Publicado: (2015)

A Novel Clinical Radiomics Nomogram to Identify Crohn’s Disease from Intestinal Tuberculosis
por: Zhu C, et al.
Publicado: (2021)

<i>Helicobacter pylori</i> infection and inflammatory bowel diseases
por: Yu. P. Uspenskiy, et al.
Publicado: (2021)

MSC therapy for inflammatory bowel disease
por: Mikhail A. Konoplyannikov, et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand?
por: Phil-Robin Tepasse, et al.
Publicado: (2021)

Enfermedades inflamatorias intestinales: Experiencia de dos centros chilenos
por: Figueroa C,Carolina, et al.
Publicado: (2005)

Rol de infliximab en enfermedad inflamatoria intestinal: Experiencia local
por: Simian,Daniela, et al.
Publicado: (2013)

Presencia de Escherichia coli intracelular en mucosa intestinal de pacientes con Enfermedad Inflamatoria Intestinal y su asociación con características clínicas y el uso de corticosteroides
por: De La Fuente,Marjorie, et al.
Publicado: (2017)

Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease
por: Laura A. Lucaciu, et al.
Publicado: (2021)

Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature
por: Turse EP, et al.
Publicado: (2018)

A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis
por: Deng J, et al.
Publicado: (2021)

Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
por: Lidiya V. Boldyreva, et al.
Publicado: (2021)

Clinical utility of ustekinumab in Crohn’s disease
por: Kotze PG, et al.
Publicado: (2018)

Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices
por: Rohan V Yewale, et al.
Publicado: (2021)

FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis
por: Eckert J, et al.
Publicado: (2017)

Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series
por: Min Jee Kim, et al.
Publicado: (2021)

Construction of ceRNA Network to Reveal Potential Biomarkers in Crohn’s Disease and Validation in a TNBS Induced Mice Model
por: Ye C, et al.
Publicado: (2021)